Exposure to Bacteriophages T4 and M13 Increases Integrin Gene Expression and Impairs Migration of Human PC-3 Prostate Cancer Cells.
PC-3
bacteriophage
cell migration
integrin
nanoparticle
prostate cancer
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
03 Oct 2021
03 Oct 2021
Historique:
received:
20
08
2021
revised:
30
09
2021
accepted:
30
09
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
The interaction between bacteriophages and integrins has been reported in different cancer cell lines, and efforts have been undertaken to understand these interactions in tumor cells along with their possible role in gene alterations, with the aim to develop new cancer therapies. Here, we report that the non-specific interaction of T4 and M13 bacteriophages with human PC-3 cells results in differential migration and varied expression of different integrins. PC-3 tumor cells (at 70% confluence) were exposed to 1 × 10
Identifiants
pubmed: 34680783
pii: antibiotics10101202
doi: 10.3390/antibiotics10101202
pmc: PMC8532711
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
ID : number 96314-2
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : number 2016/09532-3
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 310805/2018-0
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2019/19644-1
Références
Semin Cancer Biol. 2015 Dec;35:145-53
pubmed: 26297892
mBio. 2017 Nov 21;8(6):
pubmed: 29162715
Viruses. 2021 Sep 02;13(9):
pubmed: 34578333
Adv Drug Deliv Rev. 2017 Jan 1;108:25-38
pubmed: 27137110
Mol Cancer Res. 2019 Feb;17(2):398-408
pubmed: 30266752
Nat Rev Cancer. 2013 Aug;13(8):596-603
pubmed: 23864050
Adv Healthc Mater. 2016 Jan 7;5(1):88-93
pubmed: 26010471
Cancer Cell Int. 2014 Oct 03;14(1):99
pubmed: 25317077
Sci Rep. 2018 Dec 3;8(1):17559
pubmed: 30510202
Nat Commun. 2014 May 21;5:3862
pubmed: 24844558
Cancer Cell. 2019 Mar 18;35(3):347-367
pubmed: 30889378
Cancer. 2015 Jul 15;121(14):2411-21
pubmed: 25832466
Nat Commun. 2017 Dec 4;8(1):1915
pubmed: 29203765
Cell Host Microbe. 2019 Feb 13;25(2):285-299.e8
pubmed: 30763538
Differentiation. 2007 Nov;75(9):819-30
pubmed: 17999741
Lancet Oncol. 2014 Oct;15(11):e484-92
pubmed: 25281467
Metabolites. 2018 Mar 19;8(1):
pubmed: 29562689
Mediators Inflamm. 2019 Jun 12;2019:4107917
pubmed: 31308831
Adv Drug Deliv Rev. 2019 May;145:4-17
pubmed: 30659855
Viruses. 2018 Dec 25;11(1):
pubmed: 30585199
Diagnostics (Basel). 2021 Jul 16;11(7):
pubmed: 34359364
J Cell Biol. 1995 Sep;130(5):1189-96
pubmed: 7657703
Sci Rep. 2020 Jan 21;10(1):898
pubmed: 31965000
Microbiol Mol Biol Rev. 2016 Jun 01;80(3):523-43
pubmed: 27250768
Cancer Res. 2013 Oct 15;73(20):6243-53
pubmed: 23872583
Bioconjug Chem. 2014 Sep 17;25(9):1620-5
pubmed: 25134017
Acc Chem Res. 2016 Jun 21;49(6):1111-20
pubmed: 27153341
Cancers (Basel). 2013 Jan 15;5(1):27-47
pubmed: 24216697
Oncotarget. 2015 Oct 6;6(30):28949-60
pubmed: 26334393
JCI Insight. 2018 May 3;3(9):
pubmed: 29720567
J Virol. 2014 Nov;88(21):12551-7
pubmed: 25142581
Int J Oncol. 2014 Nov;45(5):1875-82
pubmed: 25190218
Nat Rev Drug Discov. 2010 May;9(5):363-6
pubmed: 20431568
Sci Rep. 2015 Oct 06;5:14802
pubmed: 26440922
Molecules. 2020 Feb 13;25(4):
pubmed: 32069856
Mol Biol Cell. 2016 Oct 1;27(19):2885-8
pubmed: 27687254
Nat Cell Biol. 2014 May;16(5):457-68
pubmed: 24747441
Prostate. 2011 Nov;71(15):1668-79
pubmed: 21432867
Trends Microbiol. 2021 Jun;29(6):528-541
pubmed: 33243546
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Sci Rep. 2016 Feb 23;6:21955
pubmed: 26903137
J Clin Invest. 1998 Jul 15;102(2):430-7
pubmed: 9664085
Hum Pathol. 2016 Feb;48:69-75
pubmed: 26772401
Viruses. 2021 Apr 09;13(4):
pubmed: 33918836
Pharmaceutics. 2021 Apr 02;13(4):
pubmed: 33918106
World J Gastroenterol. 2015 Feb 28;21(8):2323-35
pubmed: 25741138
Nucleic Acids Res. 2021 Apr 19;49(7):e38
pubmed: 33444445
Cancer Res. 1999 Apr 1;59(7):1655-64
pubmed: 10197643
Pharmacol Ther. 2014 Feb;141(2):222-33
pubmed: 24140083
Med Res Rev. 2019 Sep;39(5):2000-2025
pubmed: 30887551
Postepy Hig Med Dosw. 1958;12(2):191-2
pubmed: 13601395
iScience. 2021 Mar 09;24(4):102287
pubmed: 33855278
Pharmaceuticals (Basel). 2021 Feb 17;14(2):
pubmed: 33671476
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Molecules. 2018 Apr 04;23(4):
pubmed: 29617302
Cancers (Basel). 2017 Sep 04;9(9):
pubmed: 28869579
Science. 1987 Oct 23;238(4826):491-7
pubmed: 2821619
Aging (Albany NY). 2012 May;4(5):368-74
pubmed: 22626691
BMC Microbiol. 2009 Jan 20;9:13
pubmed: 19154575
Front Oncol. 2019 Sep 20;9:904
pubmed: 31616629
Cell Death Dis. 2014 Jan 23;5:e1012
pubmed: 24457956
Bioessays. 2015 Jan;37(1):6-9
pubmed: 25521633
Cytotechnology. 2018 Dec;70(6):1685-1695
pubmed: 30069611
Front Pharmacol. 2015 Nov 24;6:279
pubmed: 26635609
Front Pharmacol. 2017 Jan 18;8:1
pubmed: 28149278
Mol Ther. 2009 May;17(5):837-43
pubmed: 19259068
Acta Pharm Sin B. 2021 Sep;11(9):2726-2737
pubmed: 34589393
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):45-62
pubmed: 26994592
Front Microbiol. 2018 Jun 29;9:1434
pubmed: 30008710
Oncogene. 2011 Sep 29;30(39):4087-96
pubmed: 21478906
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2542-7
pubmed: 24550280
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11435-8
pubmed: 13679585
Cancer Res. 2012 Jul 15;72(14):3463-70
pubmed: 22593187
Gut. 2017 Jan;66(1):31-42
pubmed: 26370108
Bioprocess Biosyst Eng. 2014 Oct;37(10):2067-72
pubmed: 24728964
Prostate. 2010 Aug;70(11):1189-95
pubmed: 20564421